Olanzapine
- Product NDC
- 55111-263
- 11-digit product format
- 551110263
- Labeler code
- 55111
- Product ID
- 55111-263_ae2395b5-0918-65db-7001-41d52f121be7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olanzapine
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Dr.Reddy's Laboratories Limited
- Application
- ANDA076534
- Marketing category
- ANDA
- Marketing start
- 2011-10-24
- Substance
- OLANZAPINE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olanzapine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OLANZAPINE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7U69T4SZR |
| Rxcui | 312076, 314155, 351107, 351108 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55111-263-79 | Olanzapine | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 20 |
| 55111-263-81 | Olanzapine | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | | 20 |
| 55111-263-81 | Olanzapine | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 20 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| olanzapine | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| olanzapine | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| aspartame | INACTIVE INGREDIENT | Z0H242BBR1 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| Crospovidone | INACTIVE INGREDIENT | 68401960MK | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 11 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55111-263 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [DR.REDDY'S LABORATORIES LIMITED] | 20 | Current NDC, Legacy NDC, 3 package rows | 20250429_aff02cff-d079-bc82-6182-a24c4c6e09a6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55111-263-79 | 55111026379 | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (55111-263-79) | | 2011-10-24 | 0000-00-00 | No | No | Current |
| 55111-263-81 | 55111026381 | 3 BLISTER PACK in 1 CARTON (55111-263-81) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 3 blister pack | 2011-10-24 | 0000-00-00 | No | No | Current |